Literature DB >> 20676664

[Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET)].

M Nabauer1, A Gerth, P Kirchhof, A Goette, T Limbourg, C Sprenger, B Hoffmann, S Willems, N Doll, A Schuchert, M Oeff, U Ravens, T Meinertz, G Steinbeck, G Breithardt.   

Abstract

The German Competence Network on Atrial Fibrillation (AFNET) is a national interdisciplinary research network funded by the Federal Ministry of Education and Research (BMBF). AFNET was initiated in 2003 and aims at improving treatment of atrial fibrillation (AF), the most frequent sustained cardiac arrhythmia. AFNET has established a nationwide patient registry on diagnostics, therapy, course and complications of AF in Germany. The data analyzed to date demonstrate that patients with AF are likely to have multiple co-morbidities, such as hypertension, valvular heart disease, coronary artery disease, diabetes mellitus and advanced age. Oral anticoagulation is provided to the majority of patients in accordance with the recommendations given by guidelines. Further areas of research deal with the optimal duration of antiarrhythmic therapy following electrical cardioversion of atrial fibrillation and the value of strategies to prevent arrhythmogenic changes, such as fibrosis in the atria, for prevention of further episodes of atrial fibrillation. Additional registry projects were established for patients with catheter-based interventional therapy of atrial fibrillation and surgical ablation to define success, complications and long term results of these recently developed procedures more clearly. Data and insights gathered from these projects were used to further develop standards of care in two international conferences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676664     DOI: 10.1007/s00399-010-0097-7

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  18 in total

1.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse
Journal:  Eur Heart J       Date:  2001-10       Impact factor: 29.983

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.

Authors:  Robby Nieuwlaat; Stuart J Connolly
Journal:  Heart       Date:  2008-10-24       Impact factor: 5.994

4.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann
Journal:  Eur Heart J       Date:  2006-08       Impact factor: 29.983

5.  Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

Authors:  R G Tieleman; I C Van Gelder; H J Crijns; P J De Kam; M P Van Den Berg; J Haaksma; H J Van Der Woude; M A Allessie
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

6.  Rhythm control versus rate control for atrial fibrillation and heart failure.

Authors:  Denis Roy; Mario Talajic; Stanley Nattel; D George Wyse; Paul Dorian; Kerry L Lee; Martial G Bourassa; J Malcolm O Arnold; Alfred E Buxton; A John Camm; Stuart J Connolly; Marc Dubuc; Anique Ducharme; Peter G Guerra; Stefan H Hohnloser; Jean Lambert; Jean-Yves Le Heuzey; Gilles O'Hara; Ole Dyg Pedersen; Jean-Lucien Rouleau; Bramah N Singh; Lynne Warner Stevenson; William G Stevenson; Bernard Thibault; Albert L Waldo
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

7.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

8.  Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

Authors:  Wendy A Wattigney; George A Mensah; Janet B Croft
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

9.  Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.

Authors:  Paulus Kirchhof; Jeroen Bax; Carina Blomstrom-Lundquist; Hugh Calkins; A John Camm; Ricardo Cappato; Francisco Cosio; Harry Crijns; Hans-Christian Diener; Andreas Goette; Carsten W Israel; Karl-Heinz Kuck; Gregory Y H Lip; Stanley Nattel; Richard L Page; Ursula Ravens; Ulrich Schotten; Gerhard Steinbeck; Panos Vardas; Albert Waldo; Karl Wegscheider; Stephan Willems; Günter Breithardt
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

10.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

Authors:  Thomas Fetsch; Peter Bauer; Rolf Engberding; Hans P Koch; Jan Lukl; Thomas Meinertz; Michael Oeff; Ludger Seipel; Hans J Trappe; Norbert Treese; Günter Breithardt
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

View more
  1 in total

1.  [Quality improvement in Germany: a way to better electrophysiology?].

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.